Diabetes Research
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin.
Participants must have type 2 diabetes mellitus (T2DM)
Participants must be receiving basal insulin
Participants may be taking other medications to treat diabetes if they are allowed during the study
Acceptable non insulin glucose lowering therapies may include 0 to up to 3 of the following:
dipeptidyl peptidase (DPP-4) IV inhibitors
SGLT2 inhibitors
alphaglucosidase inhibitors or,
Glucagon-Like Peptide-1 (GLP-1) receptor agonist
Participants must be willing to stay on stable dose throughout the study
Participants must not have type 1 diabetes mellitus (T1DM)
Participants must not have lost or gained weight in the last 3 months
Participants must not have known liver disease
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.